Andrew received a BS in genetics from the University of California, Davis, and an MS in molecular pathogenesis and molecular medicine from the University of Chicago. He is currently pursuing his PhD in immunology here at UChicago.
Andrew's research includes the induction of immunological tolerance and its underlying mechanisms, alongside the development and evaluation of translational strategies for antigen immunotherapy.